1.The genetic analysis of 180 cases of chronic myelogenous leukemia in Xinjiang area.
Hong LIU ; Abuduer MUERBAIHE ; Wupuer GUZAILINUER
Chinese Journal of Hematology 2013;34(2):164-165
Adolescent
;
Adult
;
Aged
;
Child
;
Child, Preschool
;
China
;
epidemiology
;
Female
;
Fusion Proteins, bcr-abl
;
genetics
;
Humans
;
Infant
;
Karyotyping
;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
;
epidemiology
;
genetics
;
Male
;
Middle Aged
;
Young Adult
2.Clinical analysis of 104 patients with hematological malignancy after allogeneic hemotopoietic stem cell transplantation.
Yan CHEN ; Yajing XU ; Yan ZHU ; Gan FU ; Yi LIU ; Jie PENG ; Bin FU ; Qun HE ; Dengshu WU ; Xiaolin LI ; Xielan ZHAO ; Fangping CHEN
Journal of Central South University(Medical Sciences) 2011;36(9):859-864
OBJECTIVE:
To study the efficacy of allogeneic hemotopoietic stem cell transplantation (allo-HSCT) for hematological malignancy.
METHODS:
A total of 104 patients with hematological malignancy, who underwent allo-HSCT in Xiangya Hospital from December 1999 to January 2010, were retrospectively analyzed. Of the patients, the transplantation related mortality (TRM), relapse rate (RR), 5-year overall survival (OS) and disease free survival (DFS) were estimated by Kaplan-Meier analysis. The unfavorable prognostic factors were also statistically examined.
RESULTS:
Hematopoietic reconstitution was achieved in 101 patients. At the last data of follow-up, the incidences of severe acute graft versus host disease (aGVHD) and extensive chronic GVHD were 15.38% and 25.53%, and the TRM and RR were 15.66% and 21.76%, respectively. The estimated 5-year OS and DFS for all patients were (73.49±4.59)% and (63.10±5.32)%, respectively. Those for acute myeloid leukemia (AML) patients were (63.00±9.51)% and (49.30±9.96)%, and those for chronic myeloid leukemia (CML) patients were (83.87±5.06)% and (74.55±6.79)%, respectively. The survival analysis suggested the poor prognostic factors for allo-HSCT recipients including female sex, severe aGVHD and refractory hematological malignancy. Further multivariate analyses revealed that severe aGVHD and refractory hematological malignancy were the independent risk factors of poor prognosis for the recipients (P<0.05). The 5-year DFS of severe aGVHD and refractory hematological malignancy patients was (48.22±12.69)% and (42.09±12.31)%, respectively. The TRM of severe aGVHD, HLA-mismatched graft and unrelated donor transplant was significantly higher than that of the corresponding control groups (57.14% vs. 4.81%, 33.33% vs. 10.41%, 26.09% vs. 9.28%; P<0.05). The RR of refractory hematological malignancy was significantly higher than that of the control group (41.09% vs. 15.63%, P<0.05).
CONCLUSION
The treatment of allo-HSCT can improve the disease free survival of patients with hematological malignany and is an important therapeutic method for hematological malignancy. Severe aGVHD and refractory hematological malignancy are the independent risk factors of poor prognosis for the allo-HSCT recipients with hematological malignancy.
Adolescent
;
Adult
;
Child
;
China
;
epidemiology
;
Female
;
Graft vs Host Disease
;
epidemiology
;
Hematologic Neoplasms
;
therapy
;
Hematopoietic Stem Cell Transplantation
;
methods
;
Humans
;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
;
therapy
;
Leukemia, Myeloid, Acute
;
therapy
;
Male
;
Middle Aged
;
Retrospective Studies
;
Transplantation, Homologous
;
Young Adult
3.Surgical Roles for Spinal Involvement of Hematological Malignancies.
Sang Il KIM ; Young Hoon KIM ; Kee Yong HA ; Jae Won LEE ; Jin Woo LEE
Journal of Korean Neurosurgical Society 2017;60(5):534-539
OBJECTIVE: Patients with hematological malignancies frequently encounter spine-related symptoms, which are caused by disease itself or process of treatment. However, there is still lack of knowledge on their epidemiology and clinical courses. The purpose of this article is to review clinical presentations and surgical results for spinal involvement of hematologic malignancies. METHODS: From January 2011 to September 2014, 195 patients (98 males and 97 females) suffering from hematological malignancies combined with spinal problems were retrospectively analyzed for clinical and radiological characteristics and their clinical results. RESULTS: The most common diagnosis of hematological malignancy was multiple myeloma (96 patients, 49.7%), followed by chronic myeloid leukemia (30, 15.2%), acute myeloid leukemia (22, 11.2%), and lymphoma (15, 7.56%). The major presenting symptoms were mechanical axial pain (132, 67.7%) resulting from pathologic fractures, and followed by radiating pain (49, 25.1%). Progressive neurologic deficits were noted in 15 patients (7.7%), which revealed as cord compression by epidural mass or compressive myelopathy combined with pathologic fractures. Reconstructive surgery for neurologic compromise was done in 16 patients. Even though surgical intervention was useful for early paralysis (Frankel grade D or E), neurologic recovery was not satisfactory for the progressed paralysis (Frankel grade A or B). CONCLUSION: Hematological malignancies may cause various spinal problems related to disease progression or consequences of treatments. Conservative and palliative treatments are mainstay for these lesions. However, timely surgical interventions should be considered for the cases of pathologic fractures with progressive neurologic compromise.
Diagnosis
;
Disease Progression
;
Epidemiology
;
Fractures, Spontaneous
;
Hematologic Neoplasms*
;
Humans
;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
;
Leukemia, Myeloid, Acute
;
Lymphoma
;
Male
;
Multiple Myeloma
;
Neurologic Manifestations
;
Palliative Care
;
Paralysis
;
Retrospective Studies
;
Spinal Cord Compression
;
Spinal Cord Injuries
;
Spine
4.Incidence estimation of leukemia among Koreans.
Yoon Ok AHN ; Hong Hoe KOO ; Byung Joo PARK ; Keun Young YOO ; Moo Song LEE
Journal of Korean Medical Science 1991;6(4):299-307
This study was undertaken in order to estimate the incidence of leukemia among Koreans. Medical records were studied of patients with diagnoses of either ICD-9 038 (septicemia), or 204-208 (leukemias), or 284 (aplastic anemia), or 289 (other diseases of the blood and blood-forming organs) in the claims sent in by medical care institutions throughout the country to the Korea Medical Insurance Corporation (KMIC) during the period from January 1, 1986 to December 31, 1987. These records were abstracted in order to identify and confirm new cases of leukemia among the beneficiaries of KMIC, which covers about 10% of the whole Korean population. Using these data from the KMIC, the incidence rates of leukemia among Koreans were estimated as of July 1st, 1986 to June 30, 1987. The crude incidence rate of all types of leukemia among Koreans is estimated to be 3.45 (95% CI; 0.77-9.55) and 2.29 (95% CI; 0.28-7.81) per 100,000 in males and females, respectively. The cumulative rate for the age span 0-64 is 0.25% in males and 0.18% in females, and for the age span 0-74, 0.35% in males and 0.23% in females. The adjusted rates for the standard world population are 3.90 and 2.48 per 100,000 in males and females, respectively. The relative frequencies by type are 51.5% for AML, 21.6% for ALL, 20.2% for CML, and only 1.5% for CLL. The incidence patterns of various types of leukemia, of which this is the first report in Korea, are analyzed and presented.(ABSTRACT TRUNCATED AT 250 WORDS)
Adolescent
;
Adult
;
Age Factors
;
Aged
;
Child
;
Child, Preschool
;
Female
;
Humans
;
Incidence
;
Infant
;
Korea/epidemiology
;
Leukemia/*epidemiology
;
Leukemia, Lymphocytic, Chronic, B-Cell/epidemiology
;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive/epidemiology
;
Leukemia, Myeloid, Acute/epidemiology
;
Male
;
Middle Aged
;
Precursor Cell Lymphoblastic Leukemia-Lymphoma/epidemiology
;
Sex Factors
5.Influence of Lactate Dehydrogenase and Cyclosporine A Level on the Incidence of Acute Graft-versus-host Disease After Allogeneic Stem Cell Transplantation.
Moo Kon SONG ; Joo Seop CHUNG ; Young Mi SEOL ; Bo Ran KWON ; Ho Jin SHIN ; Young Jin CHOI ; Goon Jae CHO
Journal of Korean Medical Science 2009;24(4):555-560
Previous reports have suggested that a high serum cyclosporine A (CsA) level could result in a lower incidence of acute-graft-versus-host disease (aGVHD). An elevated serum lactate dehydrogenase (LDH) level has been reported to be an adverse predictor of outcome in stem cell transplantation (SCT) for acute myeloid leukemia. In this study, we retrospectively analyzed the records of 24 patients who received allogeneic SCT from an HLA-matched sibling donor for acute and chronic myelogenous leukemia. Univariate analysis showed that two factors (the serum CsA level at the third week after SCT and the LDH level at the third week after SCT) were significantly associated with the incidence of aGVHD among several variables (age, sex, stem cell source, cell dose, C-reactive protein, absolute lymphocyte count, conditioning regimens, and time to engraftment). A higher serum level of CsA and lower serum LDH level at the third week after SCT were associated with a lower incidence of aGVHD (P=0.015, 0.030). In multivariate analysis, the serum CsA level (hazard ratio [HR], 0.12; 95% confidence interval [CI], 0.022-0.652, P=0.0014) and serum LDH level (HR, 6.59; 95% CI, 1.197-36.316, P=0.030) at the third week after SCT were found to be independent factors that were significantly associated with the development of aGVHD. We conclude that a high CsA level and low LDH level might predict a low cumulative incidence of aGVHD after allogeneic transplantation from a matched sibling donor.
Acute Disease
;
Adult
;
Cyclosporine/*blood
;
Female
;
Graft vs Host Disease/*epidemiology/etiology
;
Humans
;
L-Lactate Dehydrogenase/*blood
;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive/therapy
;
Leukemia, Myeloid, Acute/therapy
;
Male
;
Middle Aged
;
Multivariate Analysis
;
Predictive Value of Tests
;
Retrospective Studies
;
Risk Factors
;
*Stem Cell Transplantation
;
Transplantation, Homologous